Brooks v. Outlaw (In re Integra Lifesciences Corp.)

271 So. 3d 814
CourtSupreme Court of Alabama
DecidedAugust 24, 2018
Docket1170692
StatusPublished

This text of 271 So. 3d 814 (Brooks v. Outlaw (In re Integra Lifesciences Corp.)) is published on Counsel Stack Legal Research, covering Supreme Court of Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brooks v. Outlaw (In re Integra Lifesciences Corp.), 271 So. 3d 814 (Ala. 2018).

Opinion

MAIN, Justice.

Integra LifeSciences Corporation ("Integra") petitions this Court for a writ of mandamus directing the Mobile Circuit Court to grant its motion to dismiss all claims filed against it by Tawni Brooks and her husband, Bobby Brooks. We grant the petition in part and deny it in part.

I. Facts and Procedural History

On May 19, 2014, Brooks underwent a double mastectomy and breast-reconstruction procedure at Springhill Memorial Hospital ("Springhill") in Mobile. Brooks experienced complications following her surgery, and a subsequent surgery performed on March 4, 2015, revealed that those complications were potentially related to surgical mesh implanted in her body as part of the 2014 procedure.

*816On March 1, 2016, Brooks requested a copy of her medical records from Springhill. On the form used to request the records from Springhill, Brooks explained that the reason for her records request was to determine "what kind of mesh" had been used in her procedure. Once Brooks received her records, she provided them to her attorney.

On March 19, 2016, Brooks sued the doctor who performed the procedure and various fictitiously named defendants, including "the manufacturer of the mesh used in [Brooks]'s operation." Brooks asserted claims of medical negligence, wantonness, and fraud against her doctor and asserted a product-liability claim under the Alabama Extended Manufacturer's Liability Doctrine ("AEMLD") and a breach-of-warranty claim against the fictitiously named defendants responsible for the manufacture of the surgical mesh.1 On January 31, 2017, Brooks amended her complaint to substitute Johnson & Johnson, Inc. ("Johnson"), and Ethicon, Inc. ("Ethicon"), as the defendants responsible for the manufacture of the surgical mesh used in her operation.

On March 4, 2017, counsel for Johnson and Ethicon e-mailed Brooks's counsel to inform him that the medical records they had obtained established that his clients did not manufacture the surgical-mesh products used in Brooks's procedure. The medical records obtained by Johnson and Ethicon related to Brooks's May 19, 2014, procedure included a document titled the "nursing intraop record." The nursing intraop record specifically identified the two types of surgical mesh used during Brooks's May 19, 2014, procedure: "SurgiMend Primatrix," a surgical mesh identified in the report as manufactured by TEI Biosciences, Inc. ("TEI"), a company acquired by Integra in 2015;2 and Atrium mesh, a mesh identified as manufactured by Atrium Medical Corporation ("Atrium"). Counsel for Ethicon and Johnson provided the nursing intraop record to Brooks.

On March 16, 2017, Brooks voluntarily dismissed the claims against Johnson and Ethicon and filed her second amended complaint, substituting Integra and Atrium for the fictitiously named defendants alleged to have manufactured the surgical mesh.

On May 11, 2017, Integra moved for a summary judgment as to the claims against it on the grounds that Brooks's claims were barred by the applicable statute of limitations and that the second amended complaint did not relate back to the original complaint because, before filing her complaint, Brooks was provided a copy of the nursing intraop record that specifically identified SurgiMend as the surgical mesh used in her procedure. Integra supported its motion with an affidavit of Springhill's director of health-information management attesting that Brooks was provided with a copy of the nursing intraop record on March 1, 2016.

Brooks responded to Integra's motion, contending that she had not been provided the nursing intraop record by Springhill and that she had not received that document until it was provided to her lawyer by Johnson and Ethicon's counsel on March 4, 2017. She argued that, after receiving the nursing intraop record, she promptly amended her complaint to substitute *817Integra for a fictitiously named defendant as the proper defendant manufacturer. Brooks attached her own affidavit to her response, stating that she had provided her attorney all the medical records that had been produced to her by Springhill. Brooks also attached an affidavit of her attorney, attesting that the nursing intraop record was not within the documents Brooks supplied to him.

Integra responded that, even without the nursing intraop record, Brooks had in her possession a document specifically identifying SurgiMend as a type of mesh used in her procedure. It is undisputed that the records provided to Brooks by Springhill contained the surgeon's "operative report" detailing the May 19, 2014, surgical procedure. That report mentioned SurgiMend by name, stating, in part:

"Closure of the abdominal wall defect achieved with a Prolene mesh, as well as reinforced with SurgiMend, Bovine allograft overlay achieved with 0 Prolene interrupted running fashion."

Integra argued that, with the knowledge of the specific trademarked brand name of its surgical-mesh product, Brooks, through the exercise of due diligence, should have been able to identify Integra as its manufacturer.

On March 15, 2018, the trial court entered an order denying Integra's motion for a summary judgment. This petition followed.

II. Standard of Review

" 'A writ of mandamus is an extraordinary remedy, and one petitioning for it must show: (1) a clear legal right in the petition to the order sought; (2) an imperative duty on the respondent to perform, accompanied by a refusal to do so; (3) the lack of another adequate remedy; and (4) the properly invoked jurisdiction of the court....' "

Ex parte Mobile Infirmary Ass'n, 74 So.3d 424, 427 (Ala. 2011) (quoting Ex parte Jackson, 780 So.2d 681, 684 (Ala. 2000) ).

Although mandamus will not generally issue to review the merits of an order denying a motion for a summary judgment, this Court has held that, in the "narrow class of cases involving fictitious parties and the relation-back doctrine," mandamus is the proper method by which to review the merits of a trial court's denial of a summary-judgment motion in which the defendant argues that the plaintiff's claim was barred by the applicable statute of limitations. Mobile Infirmary Ass'n, 74 So.3d at 427-28 (quoting Jackson, 780 So.2d at 684 ).

III. Analysis

This petition concerns the application of the relation-back doctrine of Rule 9(h), Ala. R. Civ. P., and Rule 15(c)(4), Ala. R. Civ. P., which " 'allow a plaintiff to avoid the bar of a statute of limitations by fictitiously naming defendants for which parties can later be substituted.' " Ex parte Chemical Lime of Ala., Inc., 916 So.2d 594, 597 (Ala. 2005) (quoting Fulmer v. Clark Equip. Co.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marsh v. Wenzel
732 So. 2d 985 (Supreme Court of Alabama, 1998)
Ex Parte Snow
764 So. 2d 531 (Supreme Court of Alabama, 1999)
Mobile Infirmary v. Delchamps
642 So. 2d 954 (Supreme Court of Alabama, 1994)
Ex Parte Hensel Phelps Constr. Co.
7 So. 3d 999 (Supreme Court of Alabama, 2008)
Harmon v. Blackwood
623 So. 2d 726 (Supreme Court of Alabama, 1993)
Ex Parte Chemical Lime of Alabama, Inc.
916 So. 2d 594 (Supreme Court of Alabama, 2005)
McWilliams v. Union Pacific Resources
569 So. 2d 702 (Supreme Court of Alabama, 1990)
Vesta Fire Ins. Corp. v. Milam & Co. Constr., Inc.
901 So. 2d 84 (Supreme Court of Alabama, 2004)
Spain v. Brown & Williamson Tobacco Corp.
872 So. 2d 101 (Supreme Court of Alabama, 2003)
Ex Parte Jackson
780 So. 2d 681 (Supreme Court of Alabama, 2000)
Fulmer v. Clark Equip. Co.
654 So. 2d 45 (Supreme Court of Alabama, 1995)
Crowl v. Kayo Oil Co.
848 So. 2d 930 (Supreme Court of Alabama, 2002)
Crawford v. Sundback
678 So. 2d 1057 (Supreme Court of Alabama, 1996)
Davis v. Mims
510 So. 2d 227 (Supreme Court of Alabama, 1987)
Clay v. Walden Joint Venture
611 So. 2d 254 (Supreme Court of Alabama, 1992)
Ex Parte Mobile Infirmary Association, 1091490 (Ala. 6-24-2011)
74 So. 3d 424 (Supreme Court of Alabama, 2011)
Templeton v. KyKenKee, Inc.
182 So. 3d 510 (Supreme Court of Alabama, 2015)
Paradise v. Highlands Medical Center
78 So. 3d 399 (Supreme Court of Alabama, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
271 So. 3d 814, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brooks-v-outlaw-in-re-integra-lifesciences-corp-ala-2018.